[go: up one dir, main page]

SI2518039T1 - Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena - Google Patents

Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena

Info

Publication number
SI2518039T1
SI2518039T1 SI200831331T SI200831331T SI2518039T1 SI 2518039 T1 SI2518039 T1 SI 2518039T1 SI 200831331 T SI200831331 T SI 200831331T SI 200831331 T SI200831331 T SI 200831331T SI 2518039 T1 SI2518039 T1 SI 2518039T1
Authority
SI
Slovenia
Prior art keywords
preparation
therapeutically valuable
derivatives
triphenylbutene derivatives
valuable triphenylbutene
Prior art date
Application number
SI200831331T
Other languages
English (en)
Inventor
Marja Sodervall
Maire Eloranta
Arja Kalapudas
Original Assignee
Forendo Pharma Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forendo Pharma Ltd. filed Critical Forendo Pharma Ltd.
Publication of SI2518039T1 publication Critical patent/SI2518039T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200831331T 2007-02-14 2008-02-13 Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena SI2518039T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88983807P 2007-02-14 2007-02-14
EP12173502.1A EP2518039B8 (en) 2007-02-14 2008-02-13 Method for the preparation of therapeutically valuable triphenylbutene derivatives

Publications (1)

Publication Number Publication Date
SI2518039T1 true SI2518039T1 (sl) 2015-02-27

Family

ID=39271403

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200830708T SI2121553T1 (sl) 2007-02-14 2008-02-13 Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
SI200831331T SI2518039T1 (sl) 2007-02-14 2008-02-13 Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200830708T SI2121553T1 (sl) 2007-02-14 2008-02-13 Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov

Country Status (18)

Country Link
US (2) US7812197B2 (sl)
EP (3) EP2518039B8 (sl)
JP (1) JP5363344B2 (sl)
KR (1) KR101510646B1 (sl)
CN (1) CN101636372B (sl)
AU (1) AU2008214530B2 (sl)
BR (2) BRPI0823326B1 (sl)
CA (1) CA2677861C (sl)
CY (1) CY1113184T1 (sl)
DK (1) DK2121553T3 (sl)
ES (3) ES2524002T3 (sl)
HR (1) HRP20141107T1 (sl)
MX (1) MX2009008660A (sl)
PL (1) PL2121553T3 (sl)
PT (1) PT2121553E (sl)
RU (1) RU2465261C2 (sl)
SI (2) SI2121553T1 (sl)
WO (1) WO2008099059A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008214530B2 (en) * 2007-02-14 2012-04-26 Hormos Medical Ltd Method for the preparation of therapeutically valuable triphenylbutene derivatives
CN102770402B (zh) * 2010-01-19 2016-01-20 坎布雷卡尔斯库加公司 制造二苯甲酮衍生物的新方法
KR101308258B1 (ko) * 2010-10-15 2013-09-13 씨제이제일제당 (주) 엔독시펜의 신규한 제조 방법
JP6174156B2 (ja) * 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
JP2015532309A (ja) * 2012-10-19 2015-11-09 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
CN103739456A (zh) * 2013-12-03 2014-04-23 镇江圣安医药有限公司 2-（对-（（z-4-氯-1,2-二苯基-1-丁烯基）苯氧基）乙醇的新型衍生物及其应用
CN104788300B (zh) * 2014-01-22 2017-01-11 南京华威医药科技开发有限公司 欧司哌米芬多晶型
CN104230723B (zh) * 2014-08-21 2016-08-24 凯莱英医药集团（天津）股份有限公司 托瑞米芬的合成方法
ES2967311T3 (es) * 2014-09-16 2024-04-29 Shionogi & Co Proceso para la preparación de ospemifeno
EP3240771B1 (en) 2014-12-29 2019-02-20 OLON S.p.A. Process for the preparation of ospemifene and fispemifene
US10138190B2 (en) 2015-01-09 2018-11-27 Glenmark Pharmaceuticals Limited Process for preparation of ospemifene
US10472312B2 (en) 2016-03-15 2019-11-12 Shionogi & Co., Ltd. Method for producing phenoxyethanol derivative
KR20240041745A (ko) 2022-09-23 2024-04-01 김민정 입체음향 베개

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2641075C2 (de) * 1975-09-29 1985-11-14 The Regents Of The University Of California, Berkeley, Calif. Verfahren zur Herstellung von symmetrischen Olefinen
JPS5422313A (en) 1977-07-22 1979-02-20 Kougai Boushi Chiyousa Kenkiyu Process for preparing nnformylamine
US4656187A (en) 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
GB2126576B (en) 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
FI77839C (fi) 1982-05-27 1989-05-10 Farmos Oy Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
US5491173A (en) 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US4729999A (en) 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5219548A (en) 1990-10-01 1993-06-15 Board Of Regents, The University Of Texas System High affinity halogenated-tamoxifen derivatives and uses thereof
US6096874A (en) 1990-10-01 2000-08-01 Board Of Regents, The University Of Texas System High affinity tamoxifen derivatives
JPH06504522A (ja) 1990-10-01 1994-05-26 ボード　オブ　リージェンツ，　ザ　ユニバーシティ　オブ　テキサス　システム 高親和性タモキシフェン誘導体とその使用
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5196435A (en) 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
US5352699A (en) 1992-04-30 1994-10-04 University Of Massachusetts Medical Center Use of retinioc acid to treat vaginal atrophy
US5446203A (en) 1992-08-25 1995-08-29 New York University Synthesis of haloenones and aryl or alkyl substituted enones or alkenes
DE4335876A1 (de) 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5461064A (en) 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
US5650425A (en) 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
US5681835A (en) 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
FI100692B (fi) 1994-05-24 1998-02-13 Leiras Oy Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
US5441986A (en) 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases
GB9418067D0 (en) 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
US5658931A (en) 1994-09-20 1997-08-19 Eli Lilly And Company Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
WO1996016646A1 (en) 1994-11-29 1996-06-06 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
GB9509572D0 (en) 1995-05-11 1995-07-05 Cancer Res Campaign Tech Cancer therapy
DE19526146A1 (de) 1995-07-07 1997-01-09 Schering Ag Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5747059A (en) 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
GB9604577D0 (en) * 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent
DE19653736C2 (de) 1996-12-12 2002-11-21 Lancaster Group Gmbh Kosmetisches Präparat mit Peptidzusatz
GB9803521D0 (en) 1998-02-19 1998-04-15 Orion Yhtymo Oy New compounds and pharmaceutical compositions thereof
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6525084B2 (en) 1998-07-23 2003-02-25 Novo Nordisk A/S Stable pharmaceutical formulation
US6245352B1 (en) 1999-04-27 2001-06-12 Eli Lilly And Company Pharmaceutical formulation
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
CO5271697A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
IL149990A0 (en) 2000-01-28 2002-12-01 Endorech Inc Selective estrogen receptor modulators in combination with estrogens
US20010034340A1 (en) 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US6245819B1 (en) 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
US6514898B2 (en) * 2000-12-15 2003-02-04 Shell Oil Company Process of preparing a fluid rare earth alkoxylation catalyst
FI111710B (fi) * 2001-05-04 2003-09-15 Hormos Medical Oy Ltd Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi
EP1424080B1 (en) 2001-08-10 2011-02-16 Takeda Pharmaceutical Company Limited Gnrh agonist combination drugs
US20070197664A1 (en) 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
ES2305350T3 (es) 2001-11-29 2008-11-01 Gtx, Inc. Prevencion y tratamiento de la osteoporosis inducida por la privacion de androgenos.
DK1509215T3 (da) 2002-06-06 2007-03-12 Hormos Medical Ltd Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US20050187302A1 (en) 2004-02-23 2005-08-25 Hormos Medical Corporation Method for treatment or prevention of osteoporosis in individuals with high bone turnover
US7405303B2 (en) 2004-02-25 2008-07-29 Smithkline Beecham Corporation Substituted quinoline compounds for use as selective estrogen receptor modulator
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
JP2008511615A (ja) 2004-09-03 2008-04-17 ホルモス メディカル リミテッド アンドロゲン欠乏症の治療法または予防法に使用する医薬調製物の製造に用いるエストロゲン受容体選択的調節物質
AU2008214530B2 (en) 2007-02-14 2012-04-26 Hormos Medical Ltd Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene

Also Published As

Publication number Publication date
BRPI0823326B1 (pt) 2021-06-29
EP2821385A2 (en) 2015-01-07
AU2008214530A1 (en) 2008-08-21
EP2518039B8 (en) 2014-12-17
CY1113184T1 (el) 2016-04-13
JP5363344B2 (ja) 2013-12-11
EP2821385B1 (en) 2016-07-27
CN101636372A (zh) 2010-01-27
EP2821385A3 (en) 2015-02-25
EP2121553A1 (en) 2009-11-25
PT2121553E (pt) 2012-07-26
BRPI0807675A2 (pt) 2011-09-13
ES2590262T3 (es) 2016-11-21
AU2008214530B2 (en) 2012-04-26
HRP20141107T1 (hr) 2015-01-02
BRPI0823326A2 (pt) 2013-10-15
MX2009008660A (es) 2009-10-13
US8293947B2 (en) 2012-10-23
RU2009134131A (ru) 2011-03-20
US7812197B2 (en) 2010-10-12
KR101510646B1 (ko) 2015-04-10
CA2677861C (en) 2015-05-19
KR20090110862A (ko) 2009-10-22
DK2121553T3 (da) 2012-07-23
JP2010518150A (ja) 2010-05-27
PL2121553T3 (pl) 2012-11-30
EP2518039A1 (en) 2012-10-31
ES2524002T3 (es) 2014-12-03
US20080207956A1 (en) 2008-08-28
ES2389961T3 (es) 2012-11-05
CN101636372B (zh) 2013-03-27
RU2465261C2 (ru) 2012-10-27
EP2121553B1 (en) 2012-06-27
HK1139379A1 (en) 2010-09-17
BRPI0807675B1 (pt) 2021-05-18
CA2677861A1 (en) 2008-08-21
HK1206003A1 (en) 2015-12-31
SI2121553T1 (sl) 2012-11-30
EP2518039A9 (en) 2013-02-13
WO2008099059A1 (en) 2008-08-21
US20110015448A1 (en) 2011-01-20
EP2518039B1 (en) 2014-08-27

Similar Documents

Publication Publication Date Title
SI2121553T1 (sl) Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
ZA200905012B (en) Process for the preparation of certain substituted sulfimines
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL206100A0 (en) Process for the preparation of macrocycle
ZA200906050B (en) Process for the preparation of a benzimidazole derivative
ZA200900551B (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
ZA200905601B (en) Improved process for the preparation of ozidized phospholipids
ZA200907191B (en) Process for the preparation of gefitiib
GB0702854D0 (en) Method for the synthesis of sucrose-6-esters
PL2151428T3 (pl) Nowy sposób syntezy agomelatyny
ZA201003241B (en) Method for the preparation of morphine compounds
IL206530A0 (en) Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
EG26332A (en) Process for the preparation of benzonoprons
PL2102174T3 (pl) Sposób wytwarzania pochodnych podstawionych cyjanofenoksy-pirymidynyloksyfenyloakrylanów
PL2155679T3 (pl) Sposób wytwarzania pochodnych 4-formyloaminopiperydyny
PT2151429E (pt) Novo processo de síntese da agomelatina
IL207557A0 (en) Process for the preparation of pregnane derivatives
ZA200901556B (en) Process for the preparation of abacavir
ZA201000802B (en) Process for the preparation of alfuzosin hydrochloride
GB2464854B (en) Process for the preparation of risperidone
EP2173695A4 (en) PROCESS FOR THE PREPARATION OF CIS-4-TERT.-BUTYLCYCLOHEXANOL
IL200230A0 (en) Method for the production of ??-ketonitriles
EP2250178A4 (en) IMPROVED PROCESS FOR THE PREPARATION OF TRIAZOL-BENZODIAZEPINE DERIVATIVES